GlaxoSmithKline ( ($GB:GSK) ) has shared an update. GlaxoSmithKline (GSK) has announced a transaction involving the purchase of 217,000 of its own ...

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK has announced the purchase of 230,000 of its own ordinary shares as part of its ongoing ...

If you are wondering whether GSK is still good value after its strong run, you are not alone. This article will walk through ...

GSK (LSE:GSK) has quietly kept shareholders happy this year, with the stock climbing about 34% year to date and roughly 42% ...

On October 31,‍ JPMorgan low‍ered its price target on GSK plc (NYSE:GSK) to 1,440 GBp fro⁠m 1,550 GBp w⁠hile maintaining an Under‌weight rating on the‍ stock, according to a report by The Fly. ‍GSK ...

GSK plc (NYSE:GSK) is one of the best pharma stocks to invest in. J.P. Morgan analyst Richard Vosser maintained a Sell rating ...

The average one-year price target for GSK (OTCPK:GLAXF) has been revised to $23.15 / share. This is an increase of 11.52% from the prior estimate of $20.76 dated November 9, 2025. The price target is ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

GlaxoSmithKline is now known simply as GSK. GSK stock trades for 13 times earnings and barely 11 times free cash flow. The pharmaceutical giant pays a 3.3% dividend yield and is growing earnings in ...